ClearVeillance was founded by Edward A. Rose, M.D., M.S.A., and Steven E. Rose, Ph.D., M.B.A., to explore a simple but difficult problem: how can laboratory information be made easier to understand without sacrificing clinical discipline?
ClearVeillance is an early-stage research and development initiative focused on rules-based laboratory-result interpretation and clinical-AI evaluation.
Their work combines clinical oversight, laboratory-result communication, product development, and empirical evaluation of ClearVeillance and the broader clinical-AI landscape.
Edward A. Rose, M.D., M.S.A., is a medical writer and former family physician with experience translating complex clinical information for patients, clinicians, researchers, regulators, and medical-device organizations. At ClearVeillance, he leads clinical governance, development of physician standards, clinical interpretation, and research involving the safety and communication of laboratory information.
Steven E. Rose, Ph.D., M.B.A., contributes to ClearVeillance research, including study conception and design, interpretation of findings, manuscript development, and consumer research on how people understand and use laboratory information.
ClearVeillance develops clinical rules, tests them against structured cases, documents limitations, and publishes research findings as the work evolves. The goal is not to hide uncertainty, but to make the reasoning, boundaries, and evidence easier to inspect.
Do not imply that software has a complete patient history or an independent license to practice medicine.
Keep material clinical content tied to identifiable versions, tests, and change records.
Write differently for patients and professionals instead of producing one generic output for everyone.
Publish limitations, setbacks, study methods, and corrections alongside favorable findings.